1.
Mult Scler J Exp Transl Clin
; 9(3): 20552173231197132, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37674981
RESUMO
Fingolimod is a multiple sclerosis disease-modifying therapy which sequestrates lymphocytes in the lymph nodes, thereby reducing peripheral blood lymphocytes. Cryptococcal infection is an important adverse effect which should be recognised. We report a case of cutaneous and central nervous system infection who presented with isolated cutaneous symptoms in the absence of neurological or systemic manifestations.